Outcomes at 3-Years in EBV+ Recipients of Deceased Donor...

Outcomes at 3-Years in EBV+ Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine.

Muehlbacher, F., Durrbach, A., Florman, S., Pestana, Medina J., Harler, M., Larsen, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-01513
Date:
July, 2014
File:
PDF, 179 KB
2014
Conversion to is in progress
Conversion to is failed